Fake retatrutide and tirzepatide pens worth around £2 million have been seized from an industrial unit in Birmingham, the UK medicines regulator announced on 15 October 2026.
Retatrutide is the experimental weight-loss injection behind some eye-catching trial headlines this year. It has not been approved for use in the UK, yet pens with its name on are being sold online and on social media.
If you have seen it advertised, or you know someone who has bought it, this raid is a useful reminder of what those pens can really be. Here is what was found, why the regulator is worried, and how to protect yourself.
Evidence note: This article is based on the Medicines and Healthcare products Regulatory Agency (MHRA) announcement of 15 October 2026 and its earlier press releases. The MHRA describes the seized pens as fake. It has not published test results showing what was inside them. Retatrutide is an investigational medicine, which means it is still being tested, and it is not approved in the UK. This article is not medical advice. Always speak to an appropriately qualified healthcare professional before making changes to your treatment.
What’s Happened?
On the night of 14 October 2026, officers from the MHRA’s Criminal Enforcement Unit and West Midlands Police raided an industrial unit in Birmingham. According to the MHRA, they seized:
- Over 12,000 fake weight-loss pens. These were labelled as retatrutide and tirzepatide. Tirzepatide is the active ingredient in Mounjaro.
- Packaging for around 30,000 more products.
The MHRA puts the value of the haul at around £2 million. It has not said how many of the pens were labelled retatrutide and how many tirzepatide, and its announcement does not mention any arrests.
Tim Duffield, Head of Intelligence at the MHRA’s Criminal Enforcement Unit, said officers found the products in a “filthy warehouse on an industrial estate”. He said they had not been assessed for safety, quality or effectiveness, and that there was no guarantee of what they contained or whether they had been contaminated.
Why Is Anyone Selling Retatrutide?
Retatrutide is a once-weekly injection being developed by Eli Lilly, the company that makes Mounjaro. It has produced large average weight losses in clinical trials, which has created a lot of excitement, and a lot of demand. You can read more about the trial results in our retatrutide UK guide.
But you cannot get it legally in the UK outside a clinical trial. The MHRA says retatrutide has not been authorised for use in the UK, and that products sold as retatrutide outside legitimate clinical trials are being supplied illegally.
It is not approved in the US yet either. In its results announcement of 5 August 2026, Lilly said it plans to apply to the US Food and Drug Administration in the first quarter of 2027. No UK approval date has been announced.
That gap between the headlines and real availability is exactly what illegal sellers exploit.
What Does “Fake” Actually Mean Here?
You will see a few different words used, and they are not quite the same:
- Fake or counterfeit means a product is pretending to be something it is not. The MHRA uses the word fake for the pens seized in Birmingham.
- Unlicensed means a product has not been approved for use in the UK. Every product sold as retatrutide is unlicensed, because there is no approved version.
- “Research use only” is a label some online sellers use. It does not make a product safe or legal to inject.
The honest answer is that nobody buying these pens can know what is inside them. A pen might contain retatrutide, the wrong amount, a different substance altogether or something contaminated. A smart label or a seller’s “lab certificate” does not change that.
Part of a Growing Series of UK Raids
The Birmingham raid is the latest in a run of MHRA operations against illegal weight-loss medicines:
- October 2025, Northampton: the first illegal weight-loss medicine production site found in the UK. At the time, the MHRA said it seized more than 2,000 retatrutide and tirzepatide pens, tens of thousands of empty pens and raw chemical ingredients. (Its October 2026 announcement gives a figure of 5,000 pens for the same raid.)
- February 2026, Lincolnshire: officers raided a farm near Sleaford and a home in Grantham, seizing almost 2,000 doses of unauthorised weight-loss medicines. The MHRA said the sites were believed to be making and distributing products including retatrutide and tirzepatide.
- May 2026, near Northampton: around 12,000 doses were recovered from a country estate in what the MHRA called its largest ever seizure of unlicensed weight-loss medicines. Two men, both aged 29, were arrested.
The MHRA says this series of operations has removed tens of thousands of doses of unauthorised weight-loss medicines from circulation. Separately, we have reported on the Alluvi Healthcare investigation, in which the MHRA had more than £200,000 frozen.
Why Are Fake Weight-Loss Pens Dangerous?
When you get a licensed medicine from a registered pharmacy, there are checks on how it is made, what is in it, how strong it is and how it is stored. With fake retatrutide from an illegal seller, none of those checks exist.
In a warning in July 2026, the MHRA said there is no guarantee that products sold as retatrutide even contain retatrutide, and that fake medicines may be contaminated with bacteria and other harmful substances. An injection also needs to be sterile, and the Birmingham pens were found in what the MHRA described as a filthy warehouse.
We have also covered reports of liver damage linked to products sold as retatrutide.
Is Fake Retatrutide Illegal in the UK?
Selling it is. The MHRA says anyone selling retatrutide in the UK is doing so illegally, because it has not been authorised for use here.
The MHRA’s advice is that prescription medicines should only come from a registered pharmacy, against a prescription from a healthcare professional. Because retatrutide is not authorised, any seller offering it in the UK is operating outside the law.
Lilly has also taken legal action in the US against companies selling products marketed as retatrutide. We explained what that means for UK readers in our article on Lilly’s lawsuit against unlicensed sellers.
How to Avoid Fake Retatrutide and Unsafe Sellers
The MHRA’s advice is simple. If you are offered a GLP-1 weight-loss medicine without the need for a prescription, walk away. It also says:
- Only use a registered pharmacy, and check it is registered with the General Pharmaceutical Council.
- Be wary of deals that seem too good to be true.
And because retatrutide is not authorised in the UK, treat any “retatrutide” for sale as illegal, whatever the website or social media post says.
The MHRA’s #FakeMeds website has more advice on buying medicines safely online.
If cost is the reason people are looking elsewhere, our retatrutide price guide explains what is actually known about future UK pricing.
What If You’ve Already Bought or Used It?
Do not use any more of it. Speak to a pharmacist or your GP about what you have taken.
If you feel unwell after using it, get medical advice promptly. For severe symptoms, get urgent help.
You can report side effects and suspected fake medicines to the MHRA through the Yellow Card scheme. Reports help the regulator spot dangerous products.
The Bottom Line
The Birmingham raid shows how quickly sellers of fake retatrutide have moved to cash in on the trial headlines. More than 12,000 fake retatrutide and tirzepatide pens were seized in a single night, along with packaging for around 30,000 more.
Retatrutide may one day become an approved medicine. Today, it is not, and anything sold as retatrutide in the UK is being supplied illegally. However convincing the pen or the website looks, there is no way to know what is inside.
Frequently Asked Questions
What was seized in the Birmingham raid?
On 14 October 2026, the MHRA and West Midlands Police seized over 12,000 fake retatrutide and tirzepatide pens, plus packaging for around 30,000 more products, from an industrial unit in Birmingham. The MHRA valued the haul at around £2 million.
Is retatrutide approved in the UK?
No. The MHRA says retatrutide has not been authorised for use in the UK. It is still being tested in clinical trials, and no UK approval date has been announced.
Is it legal to sell retatrutide in the UK?
No. The MHRA says anyone selling retatrutide in the UK is doing so illegally, and that products sold as retatrutide outside legitimate clinical trials are being supplied illegally.
How can I tell if retatrutide is fake?
You often cannot tell by looking, and every retatrutide product on sale in the UK is unlicensed. That is why the MHRA advises only getting prescription medicines from a registered pharmacy with a valid prescription. Any retatrutide offered for sale in the UK should be treated as illegal.
What should I do if I have used fake retatrutide?
Stop using it and speak to a pharmacist or GP. If you feel unwell, get medical advice promptly, and get urgent help for severe symptoms. You can report side effects and suspected fake medicines through the MHRA Yellow Card scheme.
Key Takeaways
- On 14 October 2026, the MHRA and West Midlands Police seized over 12,000 fake retatrutide and tirzepatide pens from an industrial unit in Birmingham.
- Packaging for around 30,000 more products was also seized, and the MHRA valued the haul at around £2 million.
- Retatrutide has not been authorised for use in the UK. The MHRA says anyone selling it is doing so illegally.
- The raid follows earlier MHRA operations in Northampton in October 2025 and May 2026, and in Lincolnshire in February 2026.
- There is no way to know what is inside fake retatrutide pens. They may contain the wrong substance or be contaminated.
- Only get prescription weight-loss medicines from a registered pharmacy with a valid prescription, and report suspected fakes through the Yellow Card scheme.
Further Reading
Retatrutide UK — What Is It and When Is It Coming?
Retatrutide TRIUMPH-2 Results: What the Full Type 2 Diabetes Data Actually Shows
Are Retatrutide Warnings Helping Patients Or Causing Fear?
Mounjaro UK — The Complete Plain English Guide
Sources
MHRA (24 July 2026) — No summer shortcut for safe weight loss
Eli Lilly (5 August 2026) — Lilly reports second-quarter 2026 financial results
This article is for information purposes only and does not constitute medical advice. Retatrutide is an investigational medicine and is not approved in the UK. Always consult a qualified healthcare professional before starting, stopping or changing any treatment.
Join the Briefing
Get the UK peptide medicine briefing in your inbox.
Free weekly. No spam. Unsubscribe any time.
About this article
This article is for information purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any treatment. Information correct at time of publication. The Peptide Brief updates articles when guidance changes.
UK clinic reviews
Looking for a UK weight loss clinic?
We’ve reviewed the main UK providers so you don’t have to.
